Come up with a name for your new list and we'll add to it:
NeurOP raised a round of funding on January 19, 2009. Investors include
Ariel Savannah Angel Partners.
NeurOp is a biopharmaceutical company developing new medicines to treat central nervous system disorders, including major depression, neuropathic pain and ischemia. The company's mission is to develop…